The Types segmentation classifies the market by active‑ingredient families and formulation intent, providing a granular view of product differentiation. Antifungal shampoos—primarily ketoconazole or zinc pyrithione based—address fungal scalp infections and constitute a significant portion of the scalp‑condition segment. Anti‑dandruff variants, often formulated with salicylic acid or selenium sulfide, target flaking and oil control, overlapping with both scalp‑condition and general‑hygiene applications. Antibacterial formulations, incorporating chlorhexidine or triclosan, are positioned for post‑infection care and lice prevention, supporting the general hygiene share. Eczema‑specific medicated shampoos employ colloidal oatmeal or ceramide complexes to restore barrier function, aligning with the dermatological‑condition segment. Hair‑growth products leverage minoxidil‑type or peptide‑based actives, while Coal‑tar and corticosteroid shampoos serve more severe dermatologic cases. Each type’s market contribution is proportional to its clinical efficacy, regulatory approval pathway, and parental acceptance, collectively defining the market taxonomy for Children’s Medicated Shampoo.